Select Publications
Journal articles
2024, 'Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge after Childbirth: An Australian Population-Based Cohort Study', Anesthesia and Analgesia, 138, pp. 970 - 979, http://dx.doi.org/10.1213/ANE.0000000000006582
,2022, 'Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies', British Journal of Clinical Pharmacology, 88, pp. 1298 - 1320, http://dx.doi.org/10.1111/bcp.15074
,2022, 'Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover', CANCER & METABOLISM, 10, http://dx.doi.org/10.1186/s40170-021-00278-1
,2020, 'Insulin signaling requires glucose to promote lipid anabolism in adipocytes', Journal of Biological Chemistry, 295, pp. 13250 - 13266, http://dx.doi.org/10.1074/jbc.ra120.014907
,2019, 'Extracellular fatty acids are the major contributor to lipid synthesis in prostate cancer', Molecular Cancer Research, 17, pp. 949 - 962, http://dx.doi.org/10.1158/1541-7786.MCR-18-0347
,2018, 'Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis', Molecular Oncology, 12, pp. 1623 - 1638, http://dx.doi.org/10.1002/1878-0261.12368
,2017, 'Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases', Neuropharmacology, 112, pp. 373 - 388, http://dx.doi.org/10.1016/j.neuropharm.2016.03.024
,2016, 'Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis', Frontiers in Immunology, 7, pp. 246, http://dx.doi.org/10.3389/fimmu.2016.00246
,2015, 'Expression of the kynurenine pathway in human peripheral blood mononuclear cells: Implications for inflammatory and neurodegenerative disease', PLoS ONE, 10, pp. e0131389, http://dx.doi.org/10.1371/journal.pone.0131389
,Conference Papers
2021, 'Prescription opioid use in Australian women of reproductive age from 2013 to 2020', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 308 - 309, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300627&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Posters
2024, 'Retention in opioid agonist treatment following childbirth and associated factors', Wesley Conference Centre, Sydney NSW, presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024
,Conference Presentations
2024, 'Retention in opioid agonist treatment following childbirth and associated factors', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=97s
,2024, 'Trends in the use of opioid agonist treatment for opioid dependence in pregnancy', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=1850s
,2024, 'Use of opioid agonist therapy in pregnancy: Timing of initiation and treatment retention', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=2664s
,